162 related articles for article (PubMed ID: 29607164)
21. The Prognostic Long-Term Impact of Chronic Obstructive Pulmonary Disease and Postoperative Mucostasis in Patients with Curatively Resected Non-Small Cell Lung Cancer.
Lindenmann J; Fediuk M; Fink-Neuboeck N; Mykoliuk I; Taucher E; Pichler M; Smolle J; Smolle-Juettner FM
Cells; 2023 Feb; 12(3):. PubMed ID: 36766822
[TBL] [Abstract][Full Text] [Related]
22. Spirometry at diagnosis and overall survival in non-small cell lung cancer patients.
Zhai T; Li Y; Brown R; Lanuti M; Gainor JF; Christiani DC
Cancer Med; 2022 Dec; 11(24):4796-4805. PubMed ID: 35545892
[TBL] [Abstract][Full Text] [Related]
23. Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer.
Ahn DH; Mehta N; Yorio JT; Xie Y; Yan J; Gerber DE
Clin Lung Cancer; 2013 Nov; 14(6):644-50. PubMed ID: 23886797
[TBL] [Abstract][Full Text] [Related]
24. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
25. Risk factors and cancer recurrence associated with postoperative complications after thoracoscopic lobectomy for clinical stage I non-small cell lung cancer.
Nakada T; Noda Y; Kato D; Shibasaki T; Mori S; Asano H; Matsudaira H; Hirano J; Odaka M; Ohtsuka T
Thorac Cancer; 2019 Oct; 10(10):1945-1952. PubMed ID: 31436042
[TBL] [Abstract][Full Text] [Related]
26. Thoracoscopic minimally invasive surgery for non-small cell lung cancer in patients with chronic obstructive pulmonary disease.
Cui F; Liu J; Shao W; He J
J Thorac Dis; 2013 Aug; 5 Suppl 3(Suppl 3):S260-6. PubMed ID: 24040534
[TBL] [Abstract][Full Text] [Related]
27. Comorbidity in patients undergoing surgery for lung cancer. Do we have an adequate tool to assess it?
Lembicz M; Gabryel P; Brajer-Luftmann B; Dyszkiewicz W; Batura-Gabryel H
Adv Respir Med; 2017; 85(2):55-63. PubMed ID: 28440530
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of different comorbidities in COPD patients by gender and GOLD stage.
Dal Negro RW; Bonadiman L; Turco P
Multidiscip Respir Med; 2015; 10(1):24. PubMed ID: 26246895
[TBL] [Abstract][Full Text] [Related]
29. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer.
Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW
J Thorac Oncol; 2014 Jun; 9(6):812-7. PubMed ID: 24807154
[TBL] [Abstract][Full Text] [Related]
30. Video-assisted thoracoscopic lobectomy for non-small cell lung cancer in patients with severe chronic obstructive pulmonary disease.
Wang W; Xu Z; Xiong X; Yin W; Xu X; Shao W; Chen H; He J
J Thorac Dis; 2013 Aug; 5 Suppl 3(Suppl 3):S253-9. PubMed ID: 24040533
[TBL] [Abstract][Full Text] [Related]
31. Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer.
Saber A; van der Wekken AJ; Kerner GS; van den Berge M; Timens W; Schuuring E; ter Elst A; van den Berg A; Hiltermann TJ; Groen HJ
PLoS One; 2016; 11(3):e0152317. PubMed ID: 27008036
[TBL] [Abstract][Full Text] [Related]
32. Comorbidities and their impact on chronic obstructive pulmonary disease.
Dursunoğlu N; Köktürk N; Baha A; Bilge AK; Börekçi Ş; Çiftçi F; Gezmen Karadağ M; Çalık Kütükçü E; Noyan A; Polatlı M; Önen ZP; Sarınç S; Umut S; Uzaslan E; Kubat Üzüm A; Akkoca Yıldız Ö;
Tuberk Toraks; 2016 Dec; 64(4):289-298. PubMed ID: 28393718
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic characteristics of non-small cell lung cancer in patients with smoking-related chronic obstructive pulmonary disease.
Maeda R; Tomita M; Usuda K; Uramoto H
Gen Thorac Cardiovasc Surg; 2019 Feb; 67(2):239-246. PubMed ID: 30187259
[TBL] [Abstract][Full Text] [Related]
34. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC.
Sekine Y; Behnia M; Fujisawa T
Lung Cancer; 2002 Jul; 37(1):95-101. PubMed ID: 12057873
[TBL] [Abstract][Full Text] [Related]
35. Using the BODE Index and Comorbidities to Predict Health Utilization Resources in Chronic Obstructive Pulmonary Disease.
Li CL; Lin MH; Chen PS; Tsai YC; Shen LS; Kuo HC; Liu SF
Int J Chron Obstruct Pulmon Dis; 2020; 15():389-395. PubMed ID: 32110007
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of lobectomy on pulmonary function for early stage non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD).
Wei S; Chen F; Liu R; Fu D; Wang Y; Zhang B; Ren D; Ren F; Song Z; Chen J; Xu S
Thorac Cancer; 2020 Jul; 11(7):1784-1789. PubMed ID: 32374491
[TBL] [Abstract][Full Text] [Related]
37. Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis.
Boyer MJ; Williams CD; Harpole DH; Onaitis MW; Kelley MJ; Salama JK
J Thorac Oncol; 2017 Dec; 12(12):1814-1823. PubMed ID: 28951090
[TBL] [Abstract][Full Text] [Related]
38. Video-assisted thoracoscopic surgery for primary lung cancer resections in patients with moderate to severe chronic obstructive pulmonary diseases.
Xu K; Cai W; Zeng Y; Li J; He J; Cui F; Liu J
Transl Lung Cancer Res; 2021 Jun; 10(6):2603-2613. PubMed ID: 34295665
[TBL] [Abstract][Full Text] [Related]
39. Lung cancer surgery in HIV-infected patients: An analysis of postoperative complications and long-term survival.
Wang L; Chen Y; Wang Y; Liu J; Wen Z; Chen H; Zhu Y; Wang J; Wan L; Li F; Song Y
Thorac Cancer; 2020 Aug; 11(8):2146-2154. PubMed ID: 32627360
[TBL] [Abstract][Full Text] [Related]
40. Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients.
Hashimoto N; Matsuzaki A; Okada Y; Imai N; Iwano S; Wakai K; Imaizumi K; Yokoi K; Hasegawa Y
BMC Pulm Med; 2014 Feb; 14():14. PubMed ID: 24498965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
